RESUMO
Activation of the dorsal columns is relayed to supraspinal centers, involved in pain modulation, probably via the descending fibers in the dorsolateral funiculi (DLF). The present study examines the role of the DLF in the attenuation of pain-related signs by spinal cord stimulation (SCS). Several groups of rats were subjected to nerve injury and to chronic bilateral DLF lesions at C5-7 level. In each animal, two sets of miniature electrodes were implanted, a caudal system placed in the dorsal epidural space at low thoracic level and another implanted over the dorsal column nuclei, rostral to the lesions. Stimulation (50 Hz, 0.2 ms; 70 % of motor threshold) was applied for 5 min via either of the electrodes. Behavioral tests were used to assess the effects of SCS on the nerve injury-induced mechanical and cold hypersensitivity and heat hyperalgesia. Prior to application of SCS, antagonists to either of GABAA or B, 5-HT1 or 1-2 or α/ß-adrenergic receptors were injected i.p. Both stimulations produced comparable decreases (80-90 % of the control) of neuropathic manifestations in rats with intact spinal cords. DLF lesions attenuated the effects of both types of stimulation by about 50 %. Pretreatment with receptor antagonists differentially counteracted the effects of rostral and caudal stimulation; the inhibition with rostral stimulation generally being more prominently influenced. These results provide further support to the notion of important involvement of brainstem pain modulating centers in the effects of SCS. A major component of the inhibitory spinal-supraspinal-spinal loop is mediated by fibers running in the DLF.
Assuntos
Neuralgia/terapia , Estimulação da Medula Espinal/métodos , Raízes Nervosas Espinhais/fisiologia , Antagonistas Adrenérgicos/farmacologia , Análise de Variância , Animais , Modelos Animais de Doenças , Antagonistas de Dopamina/farmacologia , Antagonistas GABAérgicos/farmacologia , Hiperalgesia/tratamento farmacológico , Limiar da Dor/efeitos dos fármacos , Limiar da Dor/fisiologia , Ratos , Ratos Sprague-Dawley , Antagonistas da Serotonina/farmacologia , Fatores de Tempo , TatoRESUMO
The possible role of the anterolateral columns (ALCs) and dorsolateral funiculi (DLF) in pain mechanisms was examined from the effects of lesions in these tracts (alone or combined) on tests for chronic deafferentation pain (autotomy) in rats. Spinal lesions alone (i.e., without denervation) in either ALC or DLF or combined DLF-ALC did not lead to any form of self-mutilation behavior. Cervical surgery, without spinal lesion, followed by limb denervation (sham) resulted in similar autotomy characteristics to those observed following limb denervation alone (control). Both results were considered as one set of controls. ALC lesions simultaneous with, or 1-2 weeks prior to limb denervation (ipsilaterally or contralaterally) produced significant delay in onset of autotomy and decrease in percentage of rats showing this behavior. DLF lesions followed by limb denervation produced significant acceleration of onset of autotomy and increase in percentage of rats showing this behavior. Combined DLF-ALC lesions with limb denervation produced intermediate effects between those observed following either ALC or DLF lesions alone. These results give further support to the concept that autotomy is related to rostral transmission of nociceptive information and that a spino-bulbo-spinal inhibitory loop involving the DLF and ALC is triggered by chronic deafferentation pain.
Assuntos
Automutilação , Medula Espinal/fisiologia , Animais , Denervação , Extremidades/inervação , Masculino , Ratos , Ratos Endogâmicos , Automutilação/etiologia , Automutilação/prevenção & controle , Medula Espinal/patologiaRESUMO
Lipopolysaccharide, also known as endotoxin (ET), is a major constituent of the outer membrane of the cell wall of most gram negative bacteria. ET is known to cause a number of pathophysiological changes associated with illness including inflammatory pain. The aim of this study is to characterize the peripheral hyperalgesia induced by ET in rats and mice. Different groups of rats and mice received different doses of ET ranging from 0.6 microgram to 40 micrograms dissolved in 50 microliters saline and injected in the plantar area of the left hind legs. All animals were subjected to tail immersion (TF), hot plate (HP) and paw pressure (PP) tests, 2-3 days prior to ET injection and during the following 1-2 days. ET injections produced a dose-dependent decrease in the latencies of the HP and PP tests of the injected leg reaching a maximum decrease of 50-60% of the control with 20-40 micrograms ET at 9 h (rats) and 24 h (mice) after the injection. Almost complete recovery was observed after 24 h in rats and 48 h in mice. TF latencies showed a less but a significant decrease while PP of the opposite leg and all tests in saline-injected animals did not elicit significant variations and served as additional controls. Our results indicate that the use of ET-produced hyperalgesia is a valid model for local and reversible inflammatory pain, with minimal distress to the animal. This model can also be used to study the efficacy of various anti-inflammatory and analgesic drugs and the molecular mechanisms of inflammation induced by bacterial invasion.
Assuntos
Endotoxinas/farmacologia , Hiperalgesia/induzido quimicamente , Inflamação/induzido quimicamente , Medição da Dor/métodos , Salmonella typhi , Animais , Comportamento Animal/efeitos dos fármacos , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Temperatura Alta , Hiperalgesia/psicologia , Imersão , Inflamação/psicologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Medição da Dor/efeitos dos fármacos , Pressão , Ratos , Ratos Sprague-Dawley , Tempo de Reação/efeitos dos fármacosRESUMO
The role of ECM-degrading proteinases in normal developmental processes and in pathological conditions is extensively studied. However, few reports describe the role ECM-degrading proteinases play in modulating hyperalgesia. The goal of this study is to describe the regulation of gelatinases during endotoxin mediated local inflammation, induced by intra plantar endotoxin (ET; 1.25 microg/50 microl) injection in Balb/c mice, and to correlate that with hyperalgesia. ET injections induced hyperalgesia, as determined by hot plate and paw pressure tests, which peaked by 24 h and recovered by 48 h post-injection. Contralateral paw of ET injected mice and saline injected paws in control mice elicited no hyperalgesia. Zymography showed that ET and saline injected paws elicited increased gelatinase activity by 9 h after injection. However, only the former maintained high levels of expression of a 90 kD gelatinase up to at least 96 h post ET injection, while in the latter gelatinase expression was down regulated by 24 h. Interestingly, the 90-kD gelatinase was upregulated in the contralateral paw of the ET-injected mice beyond 48 h post injection. Saline injection in that paw, during a time when gelatinases are upregulated, induced hyperalgesia. Intraperitoneal injection of either ZnCl(2) (100 microM), thymulin (5 microg/100 microl), or morphine (2 mg/kg/100 microl) reversed the ET-induced hyperalgesia and suppressed gelatinase activity. Furthermore, intraperitoneal injection of MPI, an ECM-degrading proteinase inhibitor, reversed ET induced hyperalgesia. Taken together, the above suggests that a functional interplay exists between gelatinase upregulation triggered by ET injections and hyperalgesia. The exact mechanism underlying such correlation remains to be determined.
Assuntos
Gelatinases/fisiologia , Membro Posterior/fisiopatologia , Hiperalgesia/fisiopatologia , Dor/fisiopatologia , Animais , Endotoxinas , Inibidores Enzimáticos/farmacologia , Membro Posterior/enzimologia , Temperatura Alta , Inflamação/enzimologia , Inflamação/fisiopatologia , Masculino , Metaloendopeptidases/antagonistas & inibidores , Camundongos , Camundongos Endogâmicos BALB C , Dor/enzimologia , Estimulação Física , Cloreto de Sódio , Fator Tímico Circulante/farmacologia , Zinco/farmacologiaRESUMO
The sympathetic system (SNS) is considered to be a major component of the neurogenic contribution to inflammation and hyperalgesia. We have investigated the role of the SNS in the local inflammatory pain induced by intraplantar (i.pl) injections of bacterial endotoxin (ET). Treatment of rats with an alpha-adrenoceptor antagonist (phentolamine, 0.25-1 mg/kg, i.p.), a beta-adrenoceptor antagonist (propranolol, 1-10 mg/kg, p.o.) or a sympathetic neuron-blocking agent (guanethedine, 30 mg/kg, s.c.) resulted in a dose-dependent reduction of the thermal hyperalgesia induced by ET. Mechanical hyperalgesia, however, was less sensitive to inhibition by propranolol and guanethedine but significantly inhibited by phentolamine. ET injection produced significant upregulation of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), IL-6, and nerve growth factor (NGF). Treatment with any one of the three sympatholytics abolished the upregulation of NGF and IL-6, while phentolamine and guanethedine also reversed the upregulation of TNF-alpha. IL-1 beta was resistant to all of the sympatholytic treatments. We conclude that the SNS can contribute to the local inflammation and hyperalgesia following injection of ET. The resistance to sympatholytics shown by IL-1 beta, known to play a key role in the inflammatory cascade, suggests that ET can initiate inflammation and hyperalgesia independently of peripheral and central sympathetic mechanisms.
Assuntos
Fibras Adrenérgicas/fisiologia , Citocinas/biossíntese , Vias Eferentes/fisiologia , Endotoxinas/toxicidade , Hiperalgesia/metabolismo , Regulação para Cima/fisiologia , Antagonistas Adrenérgicos/farmacologia , Fibras Adrenérgicas/efeitos dos fármacos , Antagonistas Adrenérgicos alfa/uso terapêutico , Animais , Relação Dose-Resposta a Droga , Vias Eferentes/efeitos dos fármacos , Temperatura Alta , Hiperalgesia/induzido quimicamente , Hiperalgesia/tratamento farmacológico , Inflamação/induzido quimicamente , Inflamação/tratamento farmacológico , Inflamação/fisiopatologia , Masculino , Fator de Crescimento Neural/metabolismo , Medição da Dor/efeitos dos fármacos , Medição da Dor/métodos , Fentolamina/uso terapêutico , Propranolol/uso terapêutico , Ratos , Ratos Sprague-Dawley , Regulação para Cima/efeitos dos fármacosRESUMO
We have recently reported that intraperitoneal (i.p.) injection of thymulin at low doses (50 ng) resulted in thermal and mechanical hyperalgesia and upregulation of the level of interleukin-1beta in the liver. In this study, we demonstrate that such injections of thymulin result in a significant elevation in the levels of TNF-alpha (P<0.01), NGF (P<0.01) and PGE(2) (P<0.01) in the liver of the treated rats, in addition to the increase in the levels of IL-1beta. Pretreatment with specific antagonists to each of these factors (polyclonal anti-TNF-alpha, anti-NGF antiserum and IL-1 receptor antagonist) did not result in the abolition of the hyperalgesia as assessed by the paw pressure, hot plate, paw immersion and tail flick tests. However, pretreatment with a combination of the above antagonist and antisera almost completely prevented thymulin-induced hyperalgesia. The cyclooxygenase inhibitor, meloxicam, reversed in a dose dependent manner (0.2, 0.4 and 2 mg/kg) thymulin effects as assessed by the different pain tests. It also abolished the thymulin-induced increase in the level of cytokines and NGF in the liver. Our results indicate that PGE(2) could be the key mediator of the hyperalgesic action of thymulin and the observed upregulation of proinflammatory cytokines and NGF.
Assuntos
Citocinas/metabolismo , Dinoprostona/metabolismo , Hiperalgesia/metabolismo , Fator Tímico Circulante/efeitos adversos , Analgésicos não Narcóticos/farmacologia , Animais , Citocinas/fisiologia , Dinoprostona/fisiologia , Relação Dose-Resposta a Droga , Hiperalgesia/induzido quimicamente , Hiperalgesia/prevenção & controle , Soros Imunes/farmacologia , Proteína Antagonista do Receptor de Interleucina 1 , Interleucina-1/metabolismo , Masculino , Meloxicam , Fator de Crescimento Neural/efeitos dos fármacos , Fator de Crescimento Neural/imunologia , Fator de Crescimento Neural/metabolismo , Dor/prevenção & controle , Medição da Dor , Ratos , Ratos Sprague-Dawley , Sialoglicoproteínas/imunologia , Sialoglicoproteínas/farmacologia , Tiazinas/farmacologia , Tiazóis/farmacologia , Fatores de Tempo , Fator de Necrose Tumoral alfa/efeitos dos fármacos , Fator de Necrose Tumoral alfa/imunologia , Fator de Necrose Tumoral alfa/metabolismoRESUMO
In the endotoxin-induced inflammation, interleukin-10 reduced significantly, and in a dose-dependent manner, the inflammatory pain as assessed by mechanical and thermal tests. The levels of Tumour Necrosis Factor (TNF)alpha and NGF were upregulated at 1.5 h whereas those of IL-1beta at 6 h after ET injection. IL-10 downregulated the levels of TNFalpha (from 4974.75 +/- 875.78 to 1008 +/- 350 pg/hind paw), NGF (from 352.9 +/- 46.7 to 33.9 +/- 2.4 pg/hind paw) and IL-1beta (from 2773.88 +/- 423.96 to 1108 +/- 399.56 pg/hind paw). These data suggest that IL-10 inhibits ET-induced hyperalgesia by downregulation of TNFalpha, IL-1beta and NGF production.
Assuntos
Endotoxinas/farmacologia , Hiperalgesia/tratamento farmacológico , Hiperalgesia/imunologia , Interleucina-10/farmacologia , Animais , Membro Posterior , Temperatura Alta , Interleucina-1/análise , Interleucina-1/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Fatores de Crescimento Neural/análise , Fatores de Crescimento Neural/metabolismo , Nociceptores/efeitos dos fármacos , Nociceptores/fisiologia , Pele/química , Pele/metabolismo , Fator de Necrose Tumoral alfa/análise , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Thymulin injection into rats (20-150 ng) i.p. caused a significant reduction in both mechanical (paw pressure test) and thermal (hot plate and tail flick tests) nociceptive thresholds. Thymulin injection also doubled IL-1beta level in the liver of these animals. Induced hyperalgesia was reversed completely by alpha-MSH related tripeptide, Lys-D-Pro-Val in low doses, which is known to antagonize IL-1beta and PGE2 induced hyperalgesia, but was only partly reversed by IL-1beta related tripeptide, Lys-D-Pro-Thr at high doses, which is known to antagonize IL-1beta induced hyperalgesia only. We conclude from these results that thymulin causes hyperalgesia and that this effect is at least in part mediated via PGE2 and its effectiveness at low concentration implies a physiological role for this thymic hormone.
Assuntos
Dinoprostona/fisiologia , Hiperalgesia/induzido quimicamente , Fator Tímico Circulante/administração & dosagem , Animais , Relação Dose-Resposta a Droga , Pé , Temperatura Alta , Hiperalgesia/fisiopatologia , Injeções , Interleucina-1/metabolismo , Interleucina-1/farmacologia , Interleucina-1beta , Fígado/metabolismo , Masculino , Hormônios Estimuladores de Melanócitos/farmacologia , Limiar da Dor/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Pressão , Ratos , Ratos Sprague-Dawley , Cauda/fisiologia , Fator Tímico Circulante/farmacologiaRESUMO
Intraplantar (i.pl.) injection of small doses of capsaicin has been shown to produce hyperalgesia and upregulation of the levels of proinflammatory cytokines. The present work aimed at investigating the possible mediation of these effects by sensory neuropeptides and mast cells. Various groups of rats received i.pl. injection of capsaicin alone or preceded by the injection of antagonists to substance P (SP), calcitonin gene-related protein (CGRP) and histamine (H1, H2) or the mast cell blocker ketotifen. All pretreatments prevented, in a dose-related manner, the capsaicin-induced hyperalgesia. The SP, H2 antagonists and ketotifen prevented the upregulation of all cytokines and nerve growth factor (NGF) levels, while the CGRP and H1 antagonists showed only attenuation of the NGF level.
Assuntos
Peptídeo Relacionado com Gene de Calcitonina/fisiologia , Capsaicina/farmacologia , Citocinas/metabolismo , Histamina/fisiologia , Hiperalgesia/metabolismo , Substância P/análogos & derivados , Substância P/fisiologia , Analgésicos/farmacologia , Animais , Comportamento Animal , Peptídeo Relacionado com Gene de Calcitonina/antagonistas & inibidores , Relação Dose-Resposta a Droga , Interações Medicamentosas , Antagonistas dos Receptores Histamínicos/farmacologia , Hiperalgesia/induzido quimicamente , Injeções Espinhais/métodos , Fator de Crescimento Neural/metabolismo , Medição da Dor/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Tempo de Reação/efeitos dos fármacos , Substância P/antagonistas & inibidores , Substância P/farmacologia , Fatores de Tempo , Regulação para Cima/efeitos dos fármacosRESUMO
Intraplantar (i.pl.) injections of thymulin have been shown to produce hyperalgesia in rats through a prostaglandin E2-dependent mechanism. This study aimed at investigating if such injections can produce sustained activation of spinal neurons by mapping the fos-like-immunoreactivity (FLI) as a marker for this activation. Our results showed that thymulin produces significant and sustained FLI in neurons located in spinal laminae known to be involved in nociception. Pretreatment with either morphine or meloxicam (a cyclooxygenase inhibitor) revealed differential effects on FLI and the hyperalgesia induced by thymulin. These findings support the hypothesis that thymulin can affect central neurons either directly or through the peripheral nerve terminals.
Assuntos
Inibidores de Ciclo-Oxigenase/farmacologia , Morfina/farmacologia , Entorpecentes/farmacologia , Proteínas Proto-Oncogênicas c-fos/biossíntese , Medula Espinal/efeitos dos fármacos , Tiazinas/farmacologia , Tiazóis/farmacologia , Fator Tímico Circulante/farmacologia , Animais , Anticorpos , Temperatura Alta , Hiperalgesia/induzido quimicamente , Hiperalgesia/imunologia , Meloxicam , Nervos Periféricos/efeitos dos fármacos , Nervos Periféricos/imunologia , Estimulação Física , Prostaglandina-Endoperóxido Sintases/metabolismo , Proteínas Proto-Oncogênicas c-fos/análise , Proteínas Proto-Oncogênicas c-fos/imunologia , Ratos , Ratos Sprague-Dawley , Medula Espinal/química , Medula Espinal/enzimologia , Fator Tímico Circulante/imunologiaRESUMO
Intraplantar (5 ng) or intraperitoneal (50 ng) injections of thymulin, produced both thermal and mechanical hyperalgesia in rats. In this report, we show that ablation of capsaicin sensitive primary afferents (CSPA) can alter or abolish thymulin-induced hyperalgesia. Different groups of rats were subjected to either treatment with capsaicin or to surgical subdiaphragmatic vagotomy (SDV). Both capsaicin and SDV reduced significantly thymulin-induced hyperalgesia. On the other hand, these treatments elicited differential effects on the modulation by thymulin of the levels of nerve growth factor and interleukin 1beta. We conclude that the hyperalgesic effects of i.p. thymulin are mainly mediated through the CSPA fibers.
Assuntos
Capsaicina/farmacologia , Hiperalgesia/imunologia , Neurônios Aferentes/efeitos dos fármacos , Neurônios Aferentes/imunologia , Fator Tímico Circulante , Animais , Hiperalgesia/induzido quimicamente , Injeções Intraperitoneais , Interleucina-1/análise , Fatores de Crescimento Neural/análise , Neurônios Aferentes/química , Limiar da Dor , Ratos , Ratos Sprague-Dawley , Vagotomia , Nervo Vago/citologia , Nervo Vago/efeitos dos fármacos , Nervo Vago/imunologiaRESUMO
In addition to its involvement in the transmission of neuropathic pain, the dorsal column system has been shown to have analgesic effects when electrically stimulated. The segmental or supraspinal origin of the analgesia, however, has not been clearly delineated. The aim of this study is to demonstrate the contribution of supraspinal mechanisms to the inhibition of allodynia and hyperalgesia in two different rat models of mononeuropathy. Mononeuropathy was induced, under deep anesthesia, in several groups of rats (n=7 each) following either the chronic constriction injury or the spared nerve injury model. Mechanical and cold allodynia were assessed by the Von Frey monofilaments and by the acetone drop test, respectively. Thermal hyperalgesia was assessed by the paw withdrawal and hot plate tests. Bipolar electrodes for dorsal column stimulation were implanted chronically in all rats on the dorsal aspect of the medulla at the level of the obex. Selective dorsal column bilateral lesions were performed at the upper cervical level in some groups of rats. Dorsal column nuclear stimulation, rostral to selective dorsal spinal lesions, produced strong inhibitory effects on the allodynia and hyperalgesia observed in both models of mononeuropathy. These effects were comparable to those observed following similar stimulations in rats with an intact spinal cord. Our results demonstrate strong inhibitory effects of dorsal column stimulation on neuropathic pain. This inhibition can be attributed to the activation of brainstem pain-modulating centers via rostral projections of the dorsal column nuclei.
Assuntos
Tronco Encefálico/fisiopatologia , Doenças do Sistema Nervoso/complicações , Manejo da Dor , Dor/etiologia , Medula Espinal/fisiopatologia , Estimulação Elétrica Nervosa Transcutânea , Animais , Hiperalgesia/fisiopatologia , Hiperestesia/fisiopatologia , Doenças do Sistema Nervoso/fisiopatologia , Dor/fisiopatologia , Ratos , Ratos Sprague-DawleyRESUMO
The immunomodulatory thymic hormone thymulin has been shown previously to possess anti-inflammatory actions in the periphery. In this study, we have examined the effect of i.c.v. injections of either endotoxin (ET) or thymulin, in separate groups of conscious rats, on pain-related behavior and cytokine levels in different areas of the brain. Furthermore, we investigated the effect of pretreatment with either i.c.v. or i.p. injections of thymulin on endotoxin-induced hyperalgesia and the effect of pretreatment with i.c.v. thymulin on endotoxin-induced up-regulation of cytokine levels. Our results demonstrate that i.c.v. injection of endotoxin (1 microg in 5 microl saline) resulted in a significant decrease in the nociceptive thresholds as assessed by different pain tests, with peak hyperalgesia at 3 h. However, thymulin at different doses, when injected (i.c.v.), had no significant effect on pain related behavior. Pretreatment (i.c.v.) with thymulin (0.1, 0.5 and 1 microg in 5 microl saline) 20 min before endotoxin (i.c.v.) injection (1 microg in 5 microl saline) reduced, in a dose dependent manner, the endotoxin-induced hyperalgesia and exerted differential effects on the up-regulated levels of cytokines in different areas of the brain. The results provide behavioral and immunochemical characterization of a rat model for intracerebral inflammation and indicates a neuroprotective role for thymulin in the CNS.
Assuntos
Citocinas/antagonistas & inibidores , Encefalite/tratamento farmacológico , Endotoxinas/farmacologia , Hiperalgesia/tratamento farmacológico , Fator Tímico Circulante/farmacologia , Animais , Citocinas/imunologia , Citocinas/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Interações Medicamentosas/fisiologia , Encefalite/induzido quimicamente , Encefalite/imunologia , Hiperalgesia/induzido quimicamente , Hiperalgesia/imunologia , Injeções Intraventriculares , Masculino , Limiar da Dor/efeitos dos fármacos , Limiar da Dor/fisiologia , Ratos , Ratos Sprague-Dawley , Fator Tímico Circulante/imunologiaRESUMO
Clinical and recent imaging reports demonstrate the involvement of various cerebral prefrontal areas in the processing of pain. This has received further confirmation from animal experimentation showing an alteration of the threshold of acute nociceptive reflexes by various manipulations in the orbito-frontal cortical areas. The present study investigates the possible involvement of this area in the modulation of neuropathic manifestations in awake rats. Several groups of rats were subjected to mononeuropathy following the spared nerve injury model, known to produce evident tactile and cold allodynia and heat hyperalgesia. The activity of the ventrolateral orbital areas was selectively blocked by using either chronic or acute injection of lidocaine, electrolytic lesion, or chemical lesion with kainic acid or 6-hydroxydopamine (6-OHDA). The effects of these manipulations were compared with those following lesion of the somatic sensorimotor cortical areas. Local injection of lidocaine resulted in a reversible depression of all neuropathic manifestations while electrolytic or chemical lesions elicited transient attenuation affecting mainly the heat hyperalgesia and to a lesser extent the cold allodynia. The magnitude of the observed effects with the different procedures used can be ranked as follows: 6-OHDAAssuntos
Mononeuropatias/fisiopatologia
, Dor/fisiopatologia
, Córtex Pré-Frontal/fisiologia
, Córtex Somatossensorial/fisiologia
, Adrenérgicos/toxicidade
, Anestésicos Locais/administração & dosagem
, Anestésicos Locais/uso terapêutico
, Animais
, Temperatura Baixa
, Modelos Animais de Doenças
, Eletricidade/efeitos adversos
, Agonistas de Aminoácidos Excitatórios/toxicidade
, Feminino
, Membro Posterior/inervação
, Membro Posterior/fisiologia
, Temperatura Alta
, Hiperalgesia/fisiopatologia
, Ácido Caínico/toxicidade
, Lidocaína/administração & dosagem
, Lidocaína/uso terapêutico
, Mononeuropatias/induzido quimicamente
, Mononeuropatias/tratamento farmacológico
, Bloqueio Nervoso/métodos
, Oxidopamina/toxicidade
, Dor/induzido quimicamente
, Dor/tratamento farmacológico
, Medição da Dor
, Limiar da Dor/efeitos dos fármacos
, Limiar da Dor/fisiologia
, Estimulação Física
, Córtex Pré-Frontal/anatomia & histologia
, Ratos
, Ratos Sprague-Dawley
, Valores de Referência
, Córtex Somatossensorial/cirurgia
RESUMO
Despite conflicting clinical and experimental evidence, textbook description of somatic sensations continues to follow a rigid dichotomy based on the concept that pain sensation is transmitted cephalad primarily through anterolateral pathways, while touch is mediated through the dorsal column pathway. This study provides an example of the dynamic rerouting in the transmission of the nociceptive signals following injuries to the peripheral and central processes of sensory neurons. In two rat models for mononeuropathy, the chronic constriction injury model [Bennett, G.J., Xie, Y.K., Pain 33 (1988) 87-107] and the spared nerve injury model [Decosterd, I., Woolf, C.J., Pain 87 (2000) 149-158], we demonstrate that selective dorsal columns lesion produced significant decrease of tactile and cold allodynias and thermal hyperalgesia which were assessed by the Von Frey hair filaments, the acetone drop test and the heat-induced paw withdrawal, respectively. These manifestations, however, can reappear 2 weeks after bilateral dorsal column lesion in rats subjected to spared nerve injury mononeuropathy and appear also in animals sustaining chronic bilateral dorsal column lesion followed by either model of mononeuropathy. Lesion of the dorsal column on the side opposite to the neuropathic leg did not alter the neuropathic manifestations in both animal models. Changes in the sequence of timing of the dorsal column lesion and induction of mononeuropathy, suggest that the effects of the former last for 1 to 2 weeks. The results of this study show that the dorsal columns are involved in neuropathic manifestations and at the same time are not necessary for their full development and persistence. Furthermore, these results shade doubts on the validity of the concept of segregation of pathways involved in the transmission of neuropathic manifestations. Therefore, principles governing acute pain transmission are not necessarily applicable to chronic pain situations. The latter conditions seem to engage other available pathways to reestablish the pain signaling system.
Assuntos
Vias Aferentes/fisiologia , Neuralgia/fisiopatologia , Plasticidade Neuronal/fisiologia , Medula Espinal/fisiologia , Animais , Doença Crônica , Temperatura Baixa , Cordotomia , Temperatura Alta , Limiar da Dor/fisiologia , Ratos , Ratos Sprague-Dawley , TatoRESUMO
The effects of a synthetic peptide analog of thymulin (PAT) were tested on nociceptive behavior in two animal models for peripheral mononeuropathy and in another two models for capsaicin-induced hyperalgesia. Treatment with PAT (0.25-25 microg/rat, i.p.) produced significant reduction of the mechanical allodynia and heat hyperalgesia in rats subjected to either chronic constriction injury (CCI) or spared nerve injury (SNI) models for mononeuropathy. Cold allodynia was moderately reduced in the CCI model. The inhibition of neuropathic manifestations peaked at 1-2 h post-treatment and disappeared in 3-4 h. Daily treatment with PAT, however, produced progressive attenuation of all neuropathic manifestations in the SNI model. On the other hand, pretreatment with similar doses of PAT produced dose-dependent reduction of the hyperalgesia induced by intraplantar injection of capsaicin (10 microg in 50 microl). The highest dose of PAT (50 microg) produced significant reduction of abdominal aversive behavior induced by i.p injection of capsaicin (20 microg in 100 microl). Compared with the effects of treatment with morphine or meloxicam (injected at single doses known to produce analgesia), PAT exerted equal or stronger inhibitory effects on neuropathic manifestations. The reported results suggest a possible direct action of PAT on afferent nerve fibers but its mechanisms remain to be determined.
Assuntos
Dor/tratamento farmacológico , Doenças do Sistema Nervoso Periférico/tratamento farmacológico , Fator Tímico Circulante/uso terapêutico , Analgésicos não Narcóticos/uso terapêutico , Analgésicos Opioides/uso terapêutico , Animais , Capsaicina/efeitos adversos , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Interações Medicamentosas , Temperatura Alta/efeitos adversos , Hiperalgesia/induzido quimicamente , Hiperalgesia/tratamento farmacológico , Ligadura/métodos , Masculino , Meloxicam , Morfina/uso terapêutico , Dor/induzido quimicamente , Limiar da Dor , Peptídeos/síntese química , Peptídeos/química , Peptídeos/uso terapêutico , Ratos , Ratos Sprague-Dawley , Tempo de Reação , Tiazinas/uso terapêutico , Tiazóis/uso terapêutico , Fator Tímico Circulante/análogos & derivados , Fatores de TempoRESUMO
In spinal unanaesthetized cats, pretreatment with semicarbazide (200 mg/kg) 2-4.5 h prior to the administration of diazepam (1-4 mg/kg) completely blocked the enhancement of the segmental dorsal root reflex by the latter compound. Pyridoxine hydrochloride (200 mg/kg), given 3.5 h after semicarbazide, restored the spinal effect of diazepam administered 1 h later. The possibility of a link between diazepam and spinal gamma-aminobutyric acid is suggested and discussed.
Assuntos
Diazepam/antagonistas & inibidores , Gânglios Espinais/efeitos dos fármacos , Semicarbazidas/farmacologia , Aminobutiratos/metabolismo , Animais , Gatos , Diazepam/administração & dosagem , Diazepam/farmacologia , Estimulação Elétrica , Gânglios Espinais/fisiologia , Injeções Intravenosas , Laminectomia , Piridoxina/administração & dosagem , Piridoxina/farmacologia , Semicarbazidas/administração & dosagem , Medula Espinal/fisiologia , Raízes Nervosas Espinhais/fisiologiaRESUMO
1. Pyrimidylpiperazine (Y-40138), a synthetic derivative of N-[1-(4-([4-(pyrimidin-2-yl)piperazin-1-yl]methyl)phenyl)cyclopropyl] acetamide, is a novel dual regulator of pro- and anti-inflammatory cytokines in vivo. The aim of the present study was to determine the signal transduction mechanisms implicated in vitro. 2. In alveolar epithelial cells, pre-treatment (30 min) with Y-40138 reduced LPS-induced biosynthesis of IL-1 beta, IL-6 and TNF-alpha, an effect paralleled by up-regulating an anti-inflammatory counter-loop mediated through IL-10. 3. This differential regulation of pro- and anti-inflammatory signals was accompanied by an inhibition of the nuclear localization of selective NF-kappa B subunits, particularly NF-kappa B(1) (p50), RelA (p65), the major transactivating member of the Rel family, RelB (p68) and c-Rel (p75). In addition, Y-40138 blockaded, in a dose-dependent manner, the LPS-induced nuclear activation of NF-kappa B. 4. Analysis of the upstream pathway involved in Y-40138-dependent retardation of LPS-induced NF-kappa B translocation/activation revealed the involvement of an I kappa B-alpha sensitive pathway. Pre-treatment with Y-40138 ameliorated LPS-induced degradation of I kappa B-alpha in the cytosolic compartment and retarded its phosphorylation, suggesting the involvement of an upstream kinase. 5. Recombinant IL-10 (0 -- 10 ng ml(-1)) blockaded, in a dose-dependent manner, LPS-induced biosynthesis of IL-1 beta, IL-6 and TNF-alpha. Furthermore, rhIL-10 reduced the DNA binding activity of NF-kappa B. Immunoneutralization of endogenous IL-10 by a polyclonal alpha IL-10 (5 microg ml(-1)) reversed the inhibitory effect of Y-40138 on pro-inflammatory cytokines and partially restored the DNA binding activity of NF-kappa B. 6. These results indicate that Y-40138 mediated dual immunoregulation of pro- and anti-inflammatory cytokines is IL-10 sensitive and mediated through the I kappa B-alpha/NF-kappa B signal transduction pathway.
Assuntos
Acetamidas/farmacologia , Células Epiteliais/efeitos dos fármacos , Proteínas I-kappa B , Interleucina-10/farmacologia , Pulmão/efeitos dos fármacos , NF-kappa B/metabolismo , Piperazinas/farmacologia , Acetamidas/imunologia , Transporte Ativo do Núcleo Celular/efeitos dos fármacos , Animais , Western Blotting , Células Cultivadas , Citocinas/biossíntese , Citocinas/metabolismo , DNA/metabolismo , Proteínas de Ligação a DNA/metabolismo , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Células Epiteliais/metabolismo , Soros Imunes/imunologia , Concentração Inibidora 50 , Interleucina-10/imunologia , Lipopolissacarídeos/antagonistas & inibidores , Lipopolissacarídeos/farmacologia , Pulmão/citologia , Pulmão/metabolismo , Modelos Biológicos , Inibidor de NF-kappaB alfa , NF-kappa B/antagonistas & inibidores , NF-kappa B/química , Fosforilação/efeitos dos fármacos , Piperazinas/imunologia , Ligação Proteica/efeitos dos fármacos , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Subunidades Proteicas , Ratos , Transdução de Sinais/efeitos dos fármacosRESUMO
1. Exposure to midrange ultraviolet radiation (UVB) is known to produce skin inflammation similar to sunburn. The aim of this study was to characterize the hyperalgesia and cytokine upregulation induced by UVB and their modulation by antiinflammatory cytokines. 2. Acute exposure of the dorsal skin of mice to UVB (200, 250 and 300 mJ cm(2)) resulted in a dose-dependent decrease in the latencies of the hot plate and tail flick tests, without evident signs of skin lesions. 3. The observed hyperalgesia displayed a biphasic temporal evolution with an acute phase (3 - 6 h) and a late (48 - 96 h) phase. 4. Exposure to UVB (300 mJ cm(2)) elicited significant upregulation of interleukin (IL)-1 beta, tumour necrosis factor (TNF)-alpha and nerve growth factor (NGF), determined by ELISA in the exposed skin. This upregulation was more important during the acute phase of hyperalgesia. 5. Daily treatment of mice, with i.p. injections of either IL-10 or IL-13 (1.5, 7.5 and 15 ng in 100 microl saline) produced a dose-dependent attenuation of the UVB-induced hyperalgesia. 6. Treatment with the highest doses of either IL-10 or IL-13, produced significant attenuation of the levels of the cytokines and NGF by UVB, with relatively more pronounced effects by IL-13. 7. Acute exposure to moderate amounts of UVB results in a systemic hyperalgesia related to the upregulation of cytokine and NGF levels, since both were prevented by treatment with antiinflammatory cytokines.
Assuntos
Citocinas/efeitos dos fármacos , Hiperalgesia/prevenção & controle , Interleucina-10/farmacologia , Interleucina-13/farmacologia , Raios Ultravioleta/efeitos adversos , Animais , Citocinas/metabolismo , Citocinas/efeitos da radiação , Relação Dose-Resposta à Radiação , Hiperalgesia/etiologia , Hiperalgesia/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Fator de Crescimento Neural/efeitos dos fármacos , Fator de Crescimento Neural/metabolismo , Fator de Crescimento Neural/efeitos da radiação , Medição da Dor , Limiar da Dor/efeitos da radiação , Fatores de Tempo , Fator de Necrose Tumoral alfa/efeitos dos fármacos , Fator de Necrose Tumoral alfa/metabolismo , Fator de Necrose Tumoral alfa/efeitos da radiaçãoRESUMO
1. Intraplantar endotoxin (ET) injection (1.25 micrograms) into the hind paw of rats resulted in a localized inflammatory hyperalgesia, as assessed by paw pressure (PP), paw immersion (PI), tail flick (TF) and hot plate (HP) tests. 2. ET injection resulted in a significant elevation in the levels of interleukin-1 beta (IL-1 beta) and nerve growth factor (NGF) in the injected foot as compared with the non-injected foot. This increase was attenuated by intraperitoneal injections of dexamethasone (200 and 400 micrograms kg-1) and to a lesser extent by indomethacin (2 and 8 mg kg-1). 3. The tripeptide Lys-D-Pro-Val, which is known to antagonize IL-1 beta and prostaglandin E2 (PGE2) reversed mechanical hyperalgesia, as assessed by the PP test, and reduced significantly thermal hyperalgesia, as assessed by the HP and TF tests. 4. IL-1ra reversed both mechanical (PP) and thermal (PI) nociceptive thresholds tested on the injected leg and significantly reduced thermal hyperalgesia, as assessed by the HP and TF tests. 5. A sheep, anti-mouse NGF antiserum reversed mechanical hyperalgesia (PP test) but had little or no effect on thermal hyperalgesia (PI, HP and TF tests). 6. Our results indicate the importance of IL-1 beta, NGF and prostaglandin E2 (PGE2) in the development of ET induced hyperalgesia and the possible existence of different mechanisms underlying thermal and mechanical as well as central and peripheral hyperalgesia.